DIO Corporation (039840) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of DIO Corporation stock KRW 10,838, price KRW 8,860, upside +22.3%, quality 69 out of 100. Rating: undervalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range 8,820 KRW – 53,700 KRW · fair‑value band 7,484 KRW – 14,191 KRW · the 8,860 KRW price screens below the 10,838 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow DIO in your weekly email
Every Wednesday you see whether DIO is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
DIO Corporation manufactures and sells dental implants in South Korea and internationally. The company offers UFII implant internal submerged and no-submerged systems, FTN implant external systems, protem implants, and UV active implant systems.
Show moreShow less
It also provides digital dental implant solutions; and dental products and cardiovascular medical devices. The company was formerly known as DSI Co., Ltd and changed its name to DIO Corporation in August 2008. DIO Corporation was founded in 1988 and is headquartered in Busan, South Korea.
Stock analysis
DIO Corporation (039840) currently trades at 8,860 KRW, while our model-based Fair Value estimate is 10,838 KRW, implying the stock looks roughly 18% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 21,049 KRW per share, and 9 of the 13 models we run sit above the 8,860 KRW price.
Bear case: the Asset-Based group reads lowest at 1,264 KRW, and 4 of the 13 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 7,484 KRW (bear) to 14,191 KRW (bull), the price of 8,860 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 69/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
DIO Corporation reported revenue of 164B KRW in FY2025 versus 150B KRW in FY2021, a compound +2.3%/yr. Reported net income was −1.4B KRW in FY2025.
Key figures
Market cap 119B KRW (≈ $87.7M) Micro · P/E ratio 5.2 · P/S ratio 0.68 · EPS (TTM) 1,727 KRW · Dividend yield 1.3% · Net margin 12.7% · Return on equity 11.5% · Return on assets (EBIT) 0.1% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 49 out of 100 (low confidence).
What moves the price
The share trades about 54% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at 22%, 039840 screens cheaper than that median.
Fair Value models
Bear7,484 KRWFair Value 10,838 KRWBull14,191 KRW
Price 8,860 KRW · Upside +22.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (1,481 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.63/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+37.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.4%
Start year 2020 (pandemic). Over 10 years: +8.4% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
25.1% (2019) → −41.8% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Little optimism in the price
The price assumes about as much growth as the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+4.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+19.1%
Yearly sales growth analysts expect, extended to five years.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +2.6% a year for the price and +16.7% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 181 stocks
Beats the industry median on 10/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score69 · Top 25%
Fair Value upside+22.3% · Top 25%
Profitability
Return on equity (12 months)11.5% · Above median
Return on assets−0.4% · Bottom 25%
Net margin (12 months)12.7% · Above median
Operating margin (12 months)12.4% · Below median
Growth and dividend
Revenue growth (quarter YoY)12.1% · Above median
Dividend yield (12 months)1.3% · Below median
Balance sheet
Debt / equity0.13× · Above median
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "DIO Corporation Fair Value". https://www.fairvalue-calculator.com/stock/039840
Frequently asked questions
Is DIO Corporation (039840) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 10,838 KRW versus a price of 8,860 KRW, about +22% upside (undervalued).
What is the fair value of 039840?
Our model-based fair value for DIO Corporation is 10,838 KRW (as of Nov 8, 2026), built from audited fundamentals. The current price: 8,860 KRW.
What is the quality score of 039840?
DIO Corporation has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for DIO Corporation (039840)?
Our model-based price target is the fair value of 10,838 KRW (as of Nov 8, 2026) from 13 valuation models. Cautious scenario 7,484 KRW, optimistic scenario 14,191 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the DIO Corporation stock forecast for 2026?
Our models put fair value at 10,838 KRW, about +22% upside versus a price of 8,860 KRW (undervalued). Cautious scenario 7,484 KRW, optimistic scenario 14,191 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of DIO Corporation (039840)?
DIO Corporation reported trailing-twelve-month revenue of about 174B KRW (latest available figure, as of Nov 8, 2026).
Does DIO Corporation pay a dividend?
DIO Corporation currently shows a dividend yield of 1.29% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of DIO Corporation (039840)?
DIO Corporation has a dividend yield of 1.3%.
What growth is priced into DIO Corporation (039840)?
For today's price to be fair in a discounted-cash-flow model, DIO Corporation would have to grow free cash flow by +4.8 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.5 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of 039840 use?
Our models discount DIO Corporation at 11.8 %: a base by market capitalisation (micro), damped by beta 0.59, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For DIO Corporation that is +4.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has DIO Corporation (039840) delivered so far?
Over the past 5 years revenue at DIO Corporation grew +6.5 % a year. The price currently implies free-cash-flow growth of +4.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of DIO Corporation (039840) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into DIO Corporation (+4.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of DIO Corporation (039840)?
The free-cash-flow yield on the price is 9.77 %: that much free cash flow DIO Corporation produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of DIO Corporation (039840)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For DIO Corporation it is 10,838 KRW per share (as of Nov 8, 2026), against a price of 8,860 KRW. It is the blended result of 13 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is DIO Corporation stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 039840 trades below its calculated fair value: price 8,860 KRW, fair value 10,838 KRW, a gap of about +22% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 039840?
No. The price is what the market pays today (8,860 KRW); the fair value is what the company's own numbers justify (10,838 KRW). For DIO Corporation the two are 1,978 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is DIO Corporation worth?
The market values DIO Corporation at about 119B KRW (market capitalisation, as of Nov 8, 2026). Per share that is 8,860 KRW; our models calculate a fair value of 10,838 KRW per share.
What do the bullish and bearish scenarios say about 039840?
Our models span a range for DIO Corporation: cautious scenario 7,484 KRW, base 10,838 KRW, optimistic 14,191 KRW per share (as of Nov 8, 2026, price 8,860 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 039840?
DIO Corporation trades at a price-to-earnings ratio of 5.2 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 10,838 KRW is built from several models across several years. Median P/E at fiscal year-end, 7 fiscal years (2016 to 2023), reported earnings: 42.0. Other multiples: P/B 0.6, P/S 0.7, EV/EBITDA 4.4.
How solid is the balance sheet of DIO Corporation (039840)?
Balance-sheet figures for DIO Corporation (as of Nov 8, 2026): return on equity 11.5%, debt of 0.13 per unit of equity. They feed the Quality Score of 69/100, which measures business quality independently of the share price.
How far is 039840 from its 52-week high?
DIO Corporation trades at 8,860 KRW, about 54% below its 52-week high of 19,300 KRW and at the low of 8,820 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 10,838 KRW is for.
Which stocks are comparable to DIO Corporation?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is DIO Corporation stock attractive at the current price?
The data as of Nov 8, 2026: price 8,860 KRW, calculated fair value 10,838 KRW (+22%), Quality Score 69/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 039840 calculated?
We run DIO Corporation through 13 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of 10,838 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. DIO Corporation currently trades 18% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of DIO Corporation (039840)?
The closing price on Nov 6, 2026 was 8,860 KRW. Our model-based fair value is 10,838 KRW, about +22% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with DIO Corporation right now?
Solid quality (69/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (7,484 KRW to 14,191 KRW) leaves room in how you read the outcome.
Key figures of DIO Corporation
How large is the market capitalisation of DIO Corporation (039840)?
The market capitalisation of DIO Corporation is 119B KRW (≈ $87.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of DIO Corporation (039840)?
The price-to-sales ratio of DIO Corporation is 0.68 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of DIO Corporation (039840)?
Earnings per share at DIO Corporation are 1,727 KRW (price ÷ EPS = P/E 5.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of DIO Corporation (039840)?
The dividend yield of DIO Corporation is 1.3% (payout 6.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of DIO Corporation (039840)?
The net margin of DIO Corporation is 12.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of DIO Corporation (039840)?
The return on equity (ROE) of DIO Corporation is 11.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of DIO Corporation (039840)?
On an EBIT basis the return on assets of DIO Corporation is 0.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of DIO Corporation (039840)?
The operating margin of DIO Corporation is 12.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at DIO Corporation (039840)?
Revenue at DIO Corporation is growing +12.1% versus a year earlier (3y avg +7.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at DIO Corporation (039840)?
Earnings per share at DIO Corporation are growing +74.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does DIO Corporation (039840) carry?
The net debt of DIO Corporation is 33.0B KRW (fiscal year 2025, ≈ 2.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch DIO Corporation in the live analysis
One click puts DIO Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 8, 2026